Related Experiment Videos
CoQ10 and L-carnitine for statin myalgia?
1Wegmans Pharmacy, 500 South Meadow Street Ithaca, Ithaca, NY 14850, USA. jjdinicol@gmail.com
Insights
Statins reduce cardiovascular events but may cause muscle pain by lowering coenzyme Q10 (CoQ10). This abstract explores if CoQ10 supplements can alleviate statin-induced myopathy, a common clinical concern.
Area of Science:
- Biochemistry
- Cardiology
- Pharmacology
Background:
- Statins are crucial for cardiovascular disease (CVD) prevention, reducing events and mortality.
- Statin efficacy stems from inhibiting HMG-CoA reductase, lowering cholesterol and mevalonate.
- Mevalonate pathway inhibition reduces coenzyme Q10 (CoQ10) production.
Purpose of the Study:
- To investigate the potential role of coenzyme Q10 (CoQ10) in mitigating statin-associated muscle pain (myopathy).
- To address the clinical question regarding CoQ10 supplementation for statin-induced myalgia.
Main Methods:
- This abstract does not specify methods, but implies a review or clinical consideration of CoQ10's role.
- Focuses on the biochemical link between statins, CoQ10, and muscle function.
Main Results:
- Statin use leads to decreased CoQ10 levels.
- Reduced CoQ10 is theorized to contribute to statin-associated muscle pain (myalgia).
Conclusions:
- Statin-induced myopathy is a significant side effect impacting patient adherence.
- The potential therapeutic benefit of CoQ10 for statin myopathy requires further clinical evaluation.
Abstract:
Statins are a standard of care in many clinical settings such as acute myocardial infarction and for patients having or at risk of cardiovascular (CV) disease. This is based on a plethora of data showing reductions in CV events and mortality. The CV benefit of statins can be partly explained by their ability to inhibit of HMG-CoA reductase, which subsequently lowers cholesterol and decreases the formation of mevalonate. However, the inhibition of the mevalonate pathway decreases the formation of coenzyme Q10 (CoQ10) within the body. It has been a long-standing theory that statin-associated muscle pain (myalgia) is caused, or at least partly contributed by, a reduction in CoQ10 levels in muscle mitochondria. One of the main side effects of statins is myalgia, which causes the patient to either stop their statin or significantly reduce the dose of their statin. The question of whether CoQ10 can help treat statin myopathy is a common one encountered by clinicians in current day practice.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology
Atherosclerosis III: Management
Skeletal Muscle Relaxants: Therapeutic Uses
Atherosclerosis IV: Nursing Management